Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Pharmacia & Upjohn reveals non-enzymatic protein glycosylation inhibitors

July 19, 1996

Janssen describes agent for decreased intestinal motility

July 19, 1996

CJ-12954: Pfizer's anti-Helicobacter pylori compound

July 19, 1996

Glaxo Wellcome describes alpha1A-adrenoceptor antagonists

July 19, 1996

Terumo discloses fibrinogen (gpIIb/IIIa) antagonists

July 19, 1996

Platelet aggregation inhibitors from Meiji Seika

July 19, 1996

Fibrinogen antagonists from DuPont Merck

July 19, 1996

Fibrinogen antagonists from Merck & Co.

July 19, 1996

BASF reveals thrombin inhibitor as thrombosis/arterial reocclusion therapy

July 19, 1996

FO-2047: Kitasato Institute's lipid peroxidation inhibitor

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...